Skip to main content
SABS logo

SABS · SAB Biotherapeutics, Inc.

$3.45 +0.01 (+0.29%) At close · Jul 28
Market Cap
$263.80M
Shares
76.46M

SAB Biotherapeutics, Inc. Earnings Call Transcripts

Every quarterly earnings call for SAB Biotherapeutics, Inc. (SABS) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Key facts CIK 1833214 CUSIP 78397T202 13F (30d) 6 filings 6 filers Visit website Investor relations